Evidence map›Paper›PMID 35538146›Full record

ArticleScientific reports2022

Apical-out airway organoids as a platform for studying viral infections and screening for antiviral drugs.

Georgios Stroulios, Tyler Brown, Giulia Moreni, Douglas Kondro, Alessandro Dei, Allen Eaves, Sharon Louis, Juan Hou, Wing Chang, Dasja Pajkrt and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Animal organoids as models for integrated One Health research.One health (Amsterdam, Netherlands) · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. New developments and applications of human organoids.Nature reviews. Molecular cell biology · 2026
    Review
  7. Preclinical human models of primary ciliary dyskinesia.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. [Establishment of an Epstein-Barr virus infection model using human nasal organoids].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  12. Tools of the trade: leveraging 3DFrontiers in pharmacology · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. The Morphological, Behavioral, and Transcriptomic Life Cycle of Anthrobots.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  17. Article
  18. Article
  19. Frontiers in allergy · 2025
    Review
  20. A novelThe European respiratory journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Georgios StrouliosSTEMCELL Technologies UK Ltd., Cambridge, UK.
Tyler BrownSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Giulia MoreniDepartment of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Douglas KondroSTEMCELL Technologies UK Ltd., Cambridge, UK.
Alessandro DeiSTEMCELL Technologies UK Ltd., Cambridge, UK.
Allen EavesSTEMCELL Technologies UK Ltd., Cambridge, UK.
Sharon LouisSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Juan HouSTEMCELL Technologies China Co. Ltd., Shanghai, China.
Wing ChangSTEMCELL Technologies UK Ltd., Cambridge, UK.
Dasja PajkrtDepartment of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Katja C WolthersDepartment of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Adithya Sridhar *Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Salvatore Simmini *STEMCELL Technologies UK Ltd., Cambridge, UK. salvatore.simmini@stemcell.com.
Wind Technologies (United Kingdom) · GBAmsterdam University Medical Centers · NLStemcell Technologies · CATerry Fox Research Institute · CAUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Airway organoids are polarized 3D epithelial structures that recapitulate the organization and many of the key functions of the in vivo tissue. They present an attractive model that can overcome some of the limitations of traditional 2D and Air-Liquid Interface (ALI) models, yet the limited accessibility of the organoids' apical side has hindered their applications in studies focusing on host-pathogen interactions. Here, we describe a scalable, fast and efficient way to generate airway organoids with the apical side externally exposed. These apical-out airway organoids are generated in an Extracellular Matrix (ECM)-free environment from 2D-expanded bronchial epithelial cells and differentiated in suspension to develop uniformly-sized organoid cultures with robust ciliogenesis. Differentiated apical-out airway organoids are susceptible to infection with common respiratory viruses and show varying responses upon treatment with antivirals. In addition to the ease of apical accessibility, these apical-out airway organoids offer an alternative in vitro model to study host-pathogen interactions in higher throughput than the traditional air-liquid interface model.

Indexed as

OrganoidsVirus DiseasesAntiviral AgentsCell DifferentiationEpithelial CellsHumansAntiviral Agents

Identifiers

PMID35538146
PMCPMC9089294
OpenAlexW4280540681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.